Company intelligence / Profile preview
ReproGo
Belfast, Northern Ireland, United Kingdomreprogo.co.uk ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
ReproGo specializes in regenerative medicine targeting vascular diseases using precision-engineered human iPSC-derived cells and organoids. Their proprietary Cell'N'Go™ platform enables rapid creation of high-purity, gene-editable human cell types suitable for research, drug discovery, and future therapeutic applications. Their lead ATMP product aims to restore vascular function with a unique xeno-free manufacturing process that reduces resource consumption while enhancing regulatory compliance. As of late 2023/early 2024, the company remains preclinical with no reported clinical results but has received recognition through innovation programs.
- Therapeutic areas
- Cardiovascular
- Modalities
- iPSC-derived cells (induced pluripotent stem cell technology)Advanced Therapy Medicinal Products (ATMPs)OrganoidsCell-based therapiesBio-printing/cell-infused bioinks for tissue engineering
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on ReproGo.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ReproGo.